menu
HOME
THE FUND
INVESTMENT STRATEGY
CORE VIEWS
PUBLICATIONS
CONTACT US
back to all research
2021
A pharmaceutical company engaged in developing and commercializing central nervous system (CNS) therapies that address specific clinical needs for people living with orphan and other CNS disorders.
download research
back to all research